We Will Elaborate On This Theme, When Back From The Mountains… Grin.

For now, suffice it to say that we've long labeled these three as the serialization of a triumvirate of self important greed -- over faithful life sciences corporate stewardship.

I'll have more on my return, but recall the Forbes headline of eight years ago, now -- as did FiercePharma last February:

. . .In 2015, Saunders became the subject of a Forbes cover story titled “Wall Street’s Drug Dealer: Five Years, Three Companies, $100 billion in M&A -- and Zero Inventions. The 44-year-old Future of Medicine. . . .”

Pulling into a very familiar stone driveway, and smiling into the cool night air of the Rockies, now. . . .

नमस्ते